RecallRadar

FDA Device recall Z-2573-2023

NanoDots, Model Numbers: a) BC30023, description: QC Set For Microstar Dots

On 2023-09-20 the FDA classified a Class II recall of NanoDots, Model Numbers: a) BC30023, description: QC Set For Microstar Dots by Landauer, citing LANDAUER received reports indicating that some nanoDots may potentially be outside of the specified range of +/-5.5% accuracy. Investigation of nanoDots indicated the presence of….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-2573-2023
ClassificationClass II
Statuscompleted
Initiated2023-07-12
Published2023-09-20
Last updated2026-09-13 11:56 UTC
CompanyLandauer
Distributionn/a

Product

NanoDots, Model Numbers: a) BC30023, description: QC Set For Microstar Dots; b) BC30083, description: nanoDot QC Set - 80kVp - Sale; c) BC30084, description: nanoDot QC Set - 80kVp - No Charge; d) BC30088, description: nanoDot Calibration Set - 80kVp - No Charge; e) BC30095, description: Dot, D1DNN, in carrier sealed in bag; f) BC30110, description: Calibration set, nanoDot; g) BC30141, description: nanoDot QC Set - Cs137 - Sale; h) BC30142, description: nanoDot Calibration set - Cs137 - Sale; radiation monitoring dosimeter used with the microSTAR readers

Reason

LANDAUER received reports indicating that some nanoDots may potentially be outside of the specified range of +/-5.5% accuracy. Investigation of nanoDots indicated the presence of a potential non-conformance in the Optical Stimulated Luminescence (OSL) material that is beamed after exposure and emits fluorescence proportional to radiation exposure.

Identifiers

code_infoUDI/DI 0860003399903, all batch numbers

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:56 UTC. Current status: completed.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2573-2023%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.